JAK2 and myeloproliferative neoplasm: In MPN, mutant CALR interacts with the thrombopoietin receptor (MPL/TPOR) promoting direct dimerization and activation of JAK2 at the endoplasmic reticulum (ER)–Golgi apparatus.